Deficiency of invariant NK T cells in Crohn's disease and ulcerative colitis

被引:33
作者
Grose, Randall H.
Thompson, Fiona M.
Baxter, Alan G.
Pellicci, Daniel G.
Cummins, Adrian G. [1 ]
机构
[1] Univ Adelaide, Basil Hetzel Inst Med Res, Adelaide, SA, Australia
[2] Univ Adelaide, Dept Med, Woodville, SA 5011, Australia
[3] Univ Adelaide, Dept Med, Adelaide, SA, Australia
[4] Queen Elizabeth Hosp, Dept Gastroenterol & Hepatol, Woodville, SA 5011, Australia
[5] Monash Univ, Cent & Eastern Clin Sch, Dept Pathol & Immunol, Clayton, Vic 3181, Australia
关键词
Crohn's disease; invariant NK T cells; ulcerative colitis;
D O I
10.1007/s10620-006-9261-7
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The aim of this study was to investigate whether immunoregulatory invariant NK T cells are deficient in Crohn's disease or ulcerative colitis. Blood was collected for flow cytometry from 106 Crohn's disease, 91 ulcerative colitis, and 155 control subjects. Invariant NK T cells were assessed by V alpha 24 and (alpha-galactosylceramide/CD1d tetramer markers. Intracellular cytokine was measured after in vitro anti-CD3 antibody stimulation. V alpha 24+ T cells were quantified in ileocolonic biopsies as mRNA by real-time PCR and by immunofluorescence. Circulating invariant NK T cells were 5.3% of the control levels in Crohn's (P < 0.001) and 7.9% of the control levels in ulcerative colitis (P < 0.001). Interleukin-4 production was impaired in Crohn's disease and ulcerative colitis. Intestinal V alpha 24 mRNA expression was 7% in Crohn's disease (P < 0.05) and 9% in ulcerative colitis (P < 0.05). Intestinal V alpha 24+ T cells were 23% in Crohn's disease but not reduced in ulcerative colitis. We conclude that invariant NK T cells are deficient in Crohn's disease and in ulcerative colitis.
引用
收藏
页码:1415 / 1422
页数:8
相关论文
共 32 条
  • [1] Parallels and distinctions between T and NKT cell development in the thymus
    Berzins, SP
    Uldrich, AP
    Pellicci, DG
    McNab, F
    Hayakawa, Y
    Smyth, MJ
    Godfrey, DI
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (03) : 269 - 275
  • [2] Duchmann R, 1995, CLIN EXP IMMUNOL, V102, P448
  • [3] Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis
    Fuss, IJ
    Heller, F
    Boirivant, M
    Leon, F
    Yoshida, M
    Fichtner-Feigl, S
    Yang, ZQ
    Exley, M
    Kitani, A
    Blumberg, RS
    Mannon, P
    Strober, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2004, 113 (10) : 1490 - 1497
  • [4] Opinion - NKT cells: what's in a name?
    Godfrey, DI
    MacDonald, HR
    Kronenberg, M
    Smyth, MJ
    Van Kaer, L
    [J]. NATURE REVIEWS IMMUNOLOGY, 2004, 4 (03) : 231 - 237
  • [5] NKT cells: facts, functions and fallacies
    Godfrey, DI
    Hammond, KJL
    Poulton, LD
    Smyth, MJ
    Baxter, AG
    [J]. IMMUNOLOGY TODAY, 2000, 21 (11): : 573 - 583
  • [6] PERITZ F-TEST - BASIC PROGRAM OF A ROBUST MULTIPLE COMPARISON TEST FOR STATISTICAL-ANALYSIS OF ALL DIFFERENCES AMONG GROUP MEANS
    HARPER, JF
    [J]. COMPUTERS IN BIOLOGY AND MEDICINE, 1984, 14 (04) : 437 - 445
  • [7] Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution
    Heller, F
    Florian, P
    Bojarski, C
    Richter, J
    Christ, M
    Hillenbrand, B
    Mankertz, J
    Gitter, AH
    Bürgel, N
    Fromm, M
    Zeitz, M
    Fuss, I
    Strober, W
    Schulzke, JD
    [J]. GASTROENTEROLOGY, 2005, 129 (02) : 550 - 564
  • [8] Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy
    Illés, Z
    Kondo, T
    Newcombe, J
    Oka, N
    Tabira, T
    Yamamura, T
    [J]. JOURNAL OF IMMUNOLOGY, 2000, 164 (08) : 4375 - 4381
  • [9] Inoue S, 1999, AM J GASTROENTEROL, V94, P2441
  • [10] Genetic control of NKT cell numbers
    Jordan, MA
    Fletcher, J
    Baxter, AG
    [J]. IMMUNOLOGY AND CELL BIOLOGY, 2004, 82 (03) : 276 - 284